A combination of curcumin, berberine and quercetin was shown to effectively inhibit the expression of E-cadherin, mesenchymal N-cadherin, β-catenin, CD44 marker and MMP9 in triple-negative breast cancer cells (Figure 5). This evidence concerns the gene CDH2 and triple-negative breast carcinoma.